DOBUTAMINE

NDC 0409-2344 · Hospira, Inc.

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameDOBUTAMINE

Dosage formINJECTION, SOLUTION, CONCENTRATE

RouteINTRAVENOUS

Active ingredient(s)DOBUTAMINE HYDROCHLORIDE

Strength12.5 mg/mL

Pharmacologic classAdrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]

Marketing categoryANDA

Packages

0409-2344-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-2344-01) / 20 mL in 1 VIAL, SINGLE-DOSE

0409-2344-02 — 10 VIAL, SINGLE-DOSE in 1 TRAY (0409-2344-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-2344-62)

0409-2344-88 — 10 VIAL, SINGLE-DOSE in 1 TRAY (0409-2344-88) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-2344-68)

J1250 — Injection, dobutamine hydrochloride, per 250 mg Medicare Part B payment limit (ASP + 6%): $7.69

FDA lists these products with the same active ingredient.

0143-9141 — Dobutamine, 0338-1073 — Dobutamine Hydrochloride, 0338-1075 — Dobutamine Hydrochloride, 0338-1077 — Dobutamine Hydrochloride, 0409-0025 — Dobutamine in Dextrose, 0409-0151 — Dobutamine in Dextrose, 0409-1100 — Dobutamine in Dextrose, 51662-1330 — DOBUTAMINE, 51662-1337 — DOBUTAMINE, 51662-1566 — DOBUTAMINE HYDROCHLORIDE, 51662-1664 — DOBUTAMINE IN DEXTROSE, 51662-1697 — DOBUTAMINE IN DEXTROSE, 51662-1705 — DOBUTAMINE IN DEXTROSE, 70436-203 — dobutamine

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.